Annual report pursuant to Section 13 and 15(d)

Stockholders Equity and StockBased Compensation (Tables)

v3.24.0.1
Stockholders Equity and StockBased Compensation (Tables)
12 Months Ended
Dec. 31, 2023
Stockholders Equity and Stock Based Compensation  
Schedule Of Share-based Compensation, Stock Options, Activity

 

 

2023

 

 

2022

 

Expected volatility

 

68.13% to 95.7%

 

 

97.58% to 115.37%

 

Risk free interest rate

 

4.21% to 5.12%

 

 

1.02% to 3.28%

 

Dividend yield rate

 

 

 

 

 

 

Expected term

 

1 – 6 years

 

 

2 – 6 years

 

Closing price per share – common stock

 

$4.31 to $4.35

 

 

$5.93 to $6.27

 

Schedule Of outstanding RSU

 

 

Number of

Shares

 

 

Weighted-

Average

Grant Date Fair Value

 

 

Aggregate

Intrinsic

Value

 

Outstanding, December 31, 2022

 

 

416,316

 

 

$ 6.52

 

 

$ 1,619,469

 

Awards granted

 

 

301,099

 

 

$ 3.91

 

 

 

 

 

Awards vested

 

 

(159,727 )

 

$ 7.06

 

 

 

 

 

Awards forfeited

 

 

 

 

$

 

 

 

 

 

Outstanding, December 31, 2023

 

 

557,688

 

 

$ 4.95

 

 

$ 1,790,178

 

Schedule Of stock option

 

 

Number of Options

 

 

Weighted Average Exercise Price

 

 

Weighted-

Average

Remaining

Contractual

Term (Years)

 

 

Aggregate

Intrinsic

Value

 

Outstanding, December 31, 2022

 

 

525,903

 

 

$ 18.74

 

 

 

4.52

 

 

$ 4,982

 

Granted

 

 

35,482

 

 

 

4.58

 

 

 

 

 

 

 

 

 

Exercised

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Forfeited

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Expired

 

 

(50,598 )

 

 

17.47

 

 

 

 

 

 

 

 

 

Outstanding, December 31, 2023

 

 

510,787

 

 

$ 17.88

 

 

 

3.84

 

 

$

 

Vested and expected to vest, December 31, 2023

 

 

510,787

 

 

$ 17.88

 

 

 

3.84

 

 

$

 

Options exercisable, December 31, 2023

 

 

498,177

 

 

$ 18.21

 

 

 

3.71

 

 

$

 

Schedule Of Stock Based Compensation Expense

 

 

Year Ended

 

 

 

December 31,

 

 

 

2023

 

 

2022

 

Research and development expenses

 

$ 0.2

 

 

$

 

General and administrative expenses

 

 

1.1

 

 

 

0.8

 

Total stock-based compensation expense

 

$ 1.3

 

 

$ 0.8